This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)
C3_PANCREAS_DUCTAL_EXALLC
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
220 |
4. Check minimum number of eventsNone |
220 |
5. Include endpointsNone |
220 |
6. Filter based on genotype QC (FinnGen only) |
220 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Ductal carcinoma of pancreas
- Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 220 | 96 | 124 |
| Unadjusted period prevalence (%) | 0.05 | 0.03 | 0.05 |
| Median age at first event (years) | 68.91 | 69.72 | 68.28 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 203
- Matched controls
- 2029
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
228.8
174
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
189.5
151
*
8500/3-C25.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of pancreas, NOS
+∞
146.1
122
*
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
303.6
137.6
127
11
A09AA02
ATC
multienzymes (lipase, protease etc.)
179.9
136.6
133
21
H02AB02
ATC
dexamethasone; systemic
341.7
134.2
123
9
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
133.5
113
*
A03FA01
ATC
metoclopramide; systemic, rectal
64.1
126.4
158
105
JLC30
NOMESCO Finland
Pancreatoduodenectomy
1157.2
125.7
110
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
114.8
99
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
185.8
113.9
111
13
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
1499.4
97.4
87
*
L01BC06
ATC
capecitabine; oral
+∞
95.6
84
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
93.1
82
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
148.1
90.4
91
11
Z51.5
ICD-10 Finland
Palliative care
81.2
73.1
80
16
8500/3-C25.0
ICD-O-3
Infiltrating duct carcinoma, NOS, of head of pancreas
+∞
71.1
64
*
N02AA05
ATC
oxycodone; systemic
19.4
66.2
113
123
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
781.0
61.1
57
*
JN4AD
NOMESCO Finland
Body CT examination
37.6
58.5
75
31
JAH01
NOMESCO Finland
Laparoscopy
61.7
58.4
67
16
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
57.0
52
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
30.5
52.4
71
35
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
636.1
51.9
49
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
51.2
47
*
UJK02
NOMESCO Finland
ERCP
54.5
45.3
53
13
K83.1
ICD-10 Finland
Obstruction of bile duct
98.3
43.0
46
6
C25.1
ICD-10 Finland
Malignant neoplasm: Body of pancreas
+∞
41.0
38
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
8.1
40.7
124
329
A04AA01
ATC
ondansetron; systemic, rectal
36.3
40.7
52
19
JN4CD
NOMESCO Finland
Very extensive body CT
50.4
39.6
47
12
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
105.4
39.5
42
5
JN4BD
NOMESCO Finland
Extensive body CT
16.3
38.4
65
57
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
82.4
36.5
40
6
TPX10
NOMESCO Finland
Implantation of vascular injection port
31.8
35.6
47
19
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
35.5
33
*
R4190
NOMESCO Finland
Nutritional therapy
41.5
34.8
43
13
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
50.8
34.6
41
10
L03AA02
ATC
filgrastim; parenteral
395.7
34.0
33
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
16.1
33.9
57
48
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
140.1
33.9
35
*
WZC30
NOMESCO Finland
Teaching
9.4
32.6
75
119
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
31.0
29
*
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
78.2
29.9
33
5
B01AB10
ATC
tinzaparin; parenteral
15.4
29.0
49
41
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
28.8
27
*
R50.9
ICD-10 Finland
Fever, unspecified
8.1
28.8
73
132
E13.9
ICD-10 Finland
Other specified diabetes mellitus, without complications
50.7
28.8
34
8
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
11.2
28.6
57
68
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
24.6
28.3
40
20
L03AA13
ATC
pegfilgrastim; parenteral
+∞
26.6
25
*
PHN73
NOMESCO Finland
Reconstruction of superior mesenteric or portal vein
+∞
26.6
25
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
9.0
26.4
60
90
A06AH03
ATC
naloxegol; oral
296.5
26.3
26
*
B01AB05
ATC
enoxaparin; parenteral
5.2
26.0
109
368
A04AA55
ATC
palonosetron, combinations; systemic
+∞
24.5
23
*
D76
ICPC
Malignant neoplasm pancreas
257.9
23.1
23
*
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
44.1
22.3
27
7
C25.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of pancreas
+∞
22.3
21
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.2
20.9
76
208
TPH07
NOMESCO Finland
Cathetrisation of artery
6.8
20.8
57
110
WW500
NOMESCO Finland
Blood transfusion
26.8
20.6
28
12
A02BC02
ATC
pantoprazole; systemic
5.1
20.5
170
1024
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
20.1
19
*
WX402
NOMESCO Finland
General anaesthesia
5.8
20.0
63
145
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.7
19.3
53
102
A04AD12
ATC
aprepitant; systemic
+∞
19.1
18
*
C25.2
ICD-10 Finland
Malignant neoplasm: Tail of pancreas
+∞
19.1
18
*
ZX120
NOMESCO Finland
Intravenous
8.1
18.7
44
67
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
40.8
18.0
22
6
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
+∞
18.0
17
*
JLC10
NOMESCO Finland
Distal pancreatectomy
196.4
17.8
18
*
JN3AD
NOMESCO Finland
Abdominal CT examination
7.9
17.7
42
65
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
69.4
17.1
19
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
16.9
16
*
C25
ICD-10 Finland
Malignant neoplasm of pancreas
+∞
16.9
16
*
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
184.5
16.8
17
*
TPH04
NOMESCO Finland
Cathetrisation of vein
4.2
16.7
75
246
JLC40
NOMESCO Finland
Total pancreatoduodenectomy
+∞
15.8
15
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
172.8
15.7
16
*
K83.0
ICD-10 Finland
Cholangitis
31.5
15.5
20
7
XX3DW
NOMESCO Finland
Time consuming IT work
8.2
15.4
35
50
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.2
15.2
51
123
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
13.7
13
*
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
149.6
13.6
14
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
30.7
13.2
17
6
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.1
13.2
118
631
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
24.5
13.1
18
8
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
5.5
13.1
40
86
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
11.2
12.9
24
24
R10.1
ICD-10 Finland
Pain localized to upper abdomen
4.0
12.7
57
181
1CD01
NOMESCO Finland
NA
+∞
12.6
12
*
JAH00
NOMESCO Finland
Laparotomy
12.9
11.6
20
17
JKE25
NOMESCO Finland
Endoscopic external drainage of bile duct
+∞
11.6
11
*
JL1AT
NOMESCO Finland
Biopsy of pancreas with ultrasound guidance
+∞
11.6
11
*
JK3NB
NOMESCO Finland
Percutaneous transhepatic cholangiography
126.9
11.5
12
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
21.6
11.3
16
8
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
9.7
11.1
22
25
R18
ICD-10 Finland
Ascites
23.0
10.9
15
7
ZX122
NOMESCO Finland
Intra-arterial
63.4
10.7
12
*
SPAT1109
SPAT
Analgesia with portable analgesic pump
115.7
10.5
11
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
10.5
10
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
10.5
10
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
+∞
10.5
10
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
+∞
10.5
10
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.1
10.4
71
304
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
15.7
10.2
16
11
D13.6
ICD-10 Finland
Benign neoplasm: Pancreas
57.8
9.7
11
*
N05BA06
ATC
lorazepam; systemic, sublingual
6.2
9.4
25
45
WX892
NOMESCO Finland
Monitored bed care
4.3
9.1
34
90
N02AX02
ATC
tramadol; systemic, rectal
2.5
9.0
107
625
A10AE04
ATC
insulin glargine; parenteral
3.8
9.0
39
119
R4110
NOMESCO Finland
Physiotherapy
2.7
8.6
69
321
WX610
NOMESCO Finland
Patient controlled analgesia
93.8
8.5
9
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.6
8.4
78
394
JK4ZT
NOMESCO Finland
Percutaneous transhepatic implantation of bile duct prothesis
+∞
8.4
8
*
8500/3-C25.1
ICD-O-3
Infiltrating duct carcinoma, NOS, of body of pancreas
+∞
8.4
8
*
B01AB04
ATC
dalteparin; parenteral
6.4
8.2
21
36
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
12.4
8.2
14
12
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
10.7
8.2
15
15
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
7.3
7
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
7.3
7
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
7.3
7
*
8500/3-C25.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of tail of pancreas
+∞
7.3
7
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
7.3
7
*
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
+∞
7.3
7
*
191
Kela drug reimbursment
Erlotinib
+∞
7.3
7
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
7.3
7
*
JL2AT
NOMESCO Finland
Cytology of pancreas with ultrasound guidance
+∞
7.3
7
*
A06AD11
ATC
lactulose; oral
3.1
7.3
42
159
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
8.4
7.2
15
19
N05AD01
ATC
haloperidol; systemic
8.4
7.2
15
19
WX004
NOMESCO Finland
Patient-controlled sedation
31.2
7.2
9
*
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
10.6
7.1
13
13
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
6.8
7.1
17
27
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
14.4
7.0
11
8
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.3
6.9
80
447
E0000UV
ATC
NA
2.3
6.8
86
499
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
23.4
6.7
9
*
WX725
NOMESCO Finland
Noninvasive ventilation
5.4
6.7
19
38
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.9
6.6
26
73
J01MA12
ATC
levofloxacin; systemic
2.6
6.5
51
230
A79
ICPC
Malignancy NOS
72.0
6.5
7
*
WX600
NOMESCO Finland
Single shot through catheter
72.0
6.5
7
*
E89.1
ICD-10 Finland
Postprocedural hypoinsulinaemia
72.0
6.5
7
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
72.0
6.5
7
*
JK3NT
NOMESCO Finland
Percutaneous transhepatic dilatation of bileducts
72.0
6.5
7
*
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
72.0
6.5
7
*
E14.9
ICD-10 Finland
Unspecified diabetes mellitus, without complications
7.4
6.3
14
20
WX002
NOMESCO Finland
Sedation and analgesia
2.5
6.3
53
251
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
27.6
6.3
8
*
C10AC01
ATC
colestyramine; oral
8.1
6.2
13
17
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
112
39
57.46
178.97
1.6
1.3
111.47
306.01
ug/g
5.60
52
22
169
576
9.34
53.03
7.7
2.1
48.24
57.30
u/l
1.10
161
533
84
157
8.04
47.19
9.4
2.0
448.62
30.58
u/l
0.57
79
132
100
239
6.84
43.76
11.7
6.2
105.09
104.04
mmol/l
1.59
100
233
59
104
7.39
34.17
1.6
1.5
—
—
—
0
0
35
7
59.05
30.39
1.3
1.1
—
—
—
0
0
159
770
4.84
26.30
6.9
3.5
—
—
—
0
0
29
6
55.33
24.96
1.6
1.0
3.57
6.05
nmol/l
—
29
6
130
559
4.24
24.96
13.3
2.1
2.30
2.35
mmol/l
3.32
124
454
177
955
5.37
24.74
39.3
6.0
3.91
4.34
e9/l
1.99
164
830
69
193
4.75
23.56
1.9
1.8
—
—
—
0
0
68
194
4.63
22.56
2.0
1.7
—
—
—
0
0
83
278
4.19
22.21
2.0
1.7
—
—
—
0
0
156
816
4.13
21.45
9.7
5.3
1.18
1.21
mmol/l
4.40
150
728
70
220
4.20
20.23
10.5
7.3
1.54
1.57
mmol/l
0.03
62
176
158
895
3.72
17.90
10.0
5.7
1.18
1.21
mmol/l
4.48
134
783
76
277
3.66
17.46
1.9
2.3
7.96
14.04
umol/l
15.42
76
251
68
234
3.76
16.98
1.8
2.4
13.26
24.93
%
13.58
56
203
77
290
3.55
16.74
2.2
1.8
30.65
29.31
s
1.09
77
277
45
116
4.62
16.62
8.4
9.0
0.77
0.72
%
0.33
45
116
45
118
4.54
16.25
8.2
9.0
1.67
1.50
%
0.36
45
118
87
392
3.02
13.61
3.5
2.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
26
53
5.43
12.51
3.3
2.7
0.21
0.43
u/ml
3.22
11
27
12
10
12.63
11.83
1.9
1.5
18.01
18.33
ug/l
—
12
10
24
54
4.87
10.30
2.1
1.6
—
—
—
0
0
33
97
3.83
10.06
5.3
7.6
26.15
25.47
mmol/l
0.66
33
97
17
29
6.27
9.75
4.8
2.7
5.47
5.01
kpa
2.13
17
29
36
116
3.51
9.58
1.8
1.4
—
—
—
0
0
16
27
6.31
9.26
1.1
1.2
—
—
—
0
0
16
27
6.31
9.26
1.1
1.1
—
—
—
0
0
150
1863
0.39
9.09
3.6
5.0
1.37
1.46
mmol/l
1.47
134
1699
152
1877
0.38
9.08
3.7
5.0
4.25
4.53
mmol/l
2.21
139
1717
109
643
2.38
9.06
4.0
2.9
—
—
—
0
0
20
44
4.90
8.78
1.2
1.3
—
—
—
0
0
14
22
6.73
8.64
1.3
1.2
—
—
—
0
0
13
19
7.21
8.54
1.1
1.1
—
—
—
0
0
12
16
7.88
8.49
1.1
1.1
—
—
—
0
0
159
1916
0.39
8.42
4.0
5.7
2.43
2.64
mmol/l
1.94
142
1747
85
485
2.23
7.29
3.5
2.7
0.33
0.45
e6/l
0.43
68
347
147
1801
0.45
6.89
3.4
4.5
1.33
1.30
mmol/l
0.21
132
1631
80
456
2.19
6.79
2.0
2.1
3.14
3.22
mg/l
0.11
74
383
40
169
2.67
6.61
4.3
6.4
1.48
1.36
mmol/l
0.33
40
162
10
8
13.02
6.14
1.6
1.1
24.20
27.25
umol/l
—
10
8
138
1695
0.50
5.46
3.6
4.6
1.99
2.00
mu/l
0.03
123
1521
8
7
11.80
4.82
1.1
1.1
—
—
—
0
0
9
11
8.47
4.60
1.1
1.1
—
—
—
0
0
163
1873
0.50
4.53
4.6
5.0
6.55
6.10
mmol/l
3.41
157
1687
72
451
1.89
4.41
4.4
3.9
0.00
0.00
estimate
0.00
21
136
10
23
4.51
4.13
1.2
1.2
—
—
—
0
0
26
115
2.43
3.89
2.0
2.3
1.43
1.17
%
0.51
26
115
6
5
12.28
3.78
1.3
1.8
—
—
—
0
0
28
131
2.30
3.71
7.4
2.4
1.21
1.22
mmol/l
0.20
28
110
49
289
1.89
3.54
3.7
2.9
3.11
2.07
e6/l
0.22
25
149
37
198
2.04
3.52
2.9
3.3
5.69
5.78
kpa
0.23
37
191
110
1371
0.60
3.34
3.2
3.7
15.19
14.96
pmol/l
0.41
97
1229
61
393
1.76
3.30
4.2
4.1
52.87
248.52
ng/l
1.29
53
328
9
19
4.89
3.27
1.2
1.3
—
—
—
0
0
11
33
3.46
3.24
1.5
1.4
—
—
—
0
0
11
33
3.46
3.24
1.5
1.4
—
—
—
0
0
36
197
1.99
3.22
3.0
3.3
2.56
2.04
mmol/l
0.37
28
161
152
1744
0.58
3.19
49.3
11.8
84.15
75.97
ml/min/173m2
6.33
143
1399
7
12
5.98
3.04
1.0
1.0
—
—
—
0
0
8
17
4.84
2.94
1.3
1.3
—
—
—
0
0
31
167
2.00
2.90
2.9
2.7
4.60
4.43
kpa
0.12
31
159
49
311
1.74
2.76
3.5
2.6
0.83
1.00
e6/l
0.24
25
170
12
43
2.89
2.69
1.6
1.1
—
—
—
0
0
7
15
4.78
2.62
1.3
1.9
3.34
249.53
u/ml
—
7
15
7
16
4.48
2.49
1.0
1.4
—
—
—
0
0
0
64
0.00
2.47
0.0
1.7
—
3.36
—
0
48
86
657
1.51
2.23
4.6
3.9
—
—
—
0
0
11
42
2.70
2.22
1.1
1.3
—
—
—
0
0
7
19
3.77
2.17
1.1
1.2
—
—
—
0
0
0
56
0.00
2.09
0.0
1.2
—
2.85
—
0
11
56
395
1.56
2.07
4.7
4.1
1.02
1.02
kg/l
0.09
12
61
106
855
1.46
2.06
5.2
5.1
0.00
0.00
estimate
0.00
22
139
21
112
1.97
2.04
2.0
1.6
—
—
—
0
0
31
477
0.59
1.97
2.1
2.8
0.77
0.73
ug/l
0.06
21
320
5
11
4.62
1.95
1.0
1.2
—
—
—
0
0
5
11
4.62
1.95
1.0
1.2
—
—
—
0
0
5
11
4.62
1.95
1.0
1.2
—
—
—
0
0
107
872
1.44
1.93
4.2
3.7
0.00
0.00
estimate
0.00
22
135
0
51
0.00
1.91
0.0
1.1
—
1.04
—
0
5
0
54
0.00
1.88
0.0
1.2
—
—
—
0
0
100
808
1.44
1.88
4.2
3.7
18.83
85.79
ng/l
1.01
77
602
7
23
3.11
1.81
4.7
2.9
63.14
58.43
%
—
7
23
29
180
1.70
1.78
7.4
2.8
—
—
—
0
0
103
848
1.40
1.70
4.2
3.7
0.00
0.00
estimate
0.00
23
140
6
20
3.05
1.59
1.8
1.1
—
—
—
0
0
0
43
0.00
1.54
0.0
1.3
—
44.46
—
0
5
6
21
2.91
1.51
1.8
1.0
—
—
—
0
0
9
39
2.36
1.45
1.1
1.3
—
—
—
0
0
170
1824
0.70
1.34
7.3
6.6
44.23
40.63
mmol/mol
3.36
164
1679
71
862
0.74
1.28
3.7
3.9
2.35
2.05
ug/l
0.37
64
768
36
261
1.45
1.17
26.3
7.1
—
—
—
0
0
88
741
1.31
1.15
2.2
2.2
63.37
77.34
nmol/l
5.29
83
641
5
21
2.41
1.09
2.0
1.0
—
—
—
0
0
5
21
2.41
1.09
2.0
1.0
—
—
—
0
0
5
21
2.41
1.09
2.0
1.0
—
—
—
0
0
5
21
2.41
1.09
2.0
1.0
—
—
—
0
0
6
122
0.48
1.09
1.2
2.0
—
—
—
0
0
10
52
1.97
1.08
1.1
1.2
—
—
—
0
0
7
34
2.09
1.04
1.7
1.2
—
—
—
0
0
5
23
2.20
0.98
1.0
1.0
—
—
—
0
0
0
29
0.00
0.98
0.0
1.2
—
13.25
—
0
12
6
119
0.49
0.97
1.2
1.4
—
46.71
—
0
11
12
70
1.76
0.94
1.3
1.3
—
—
—
0
0
9
52
1.76
0.93
1.1
1.2
—
—
—
0
0
187
1951
0.72
0.88
64.4
15.5
69.63
80.70
umol/l
8.91
187
1951
11
66
1.70
0.80
1.9
3.4
—
—
—
0
0
0
24
0.00
0.79
0.0
1.2
—
1.29
—
0
7
0
24
0.00
0.79
0.0
1.1
—
—
—
0
0
0
26
0.00
0.79
0.0
1.1
—
—
—
0
0
15
99
1.55
0.78
7.9
9.4
24.67
25.15
mmol/l
0.49
15
89
47
384
1.28
0.75
1.7
1.7
1521.29
1192.27
nmol/l
1.43
40
291
5
24
2.11
0.75
1.4
1.1
—
—
—
0
0
5
24
2.11
0.75
1.4
1.4
—
—
—
0
0
5
25
2.02
0.73
1.0
1.0
1.89
1.51
g/l
—
5
20
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
0
20
0.00
0.60
0.0
1.0
—
580.36
—
0
14
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
0
20
0.00
0.60
0.0
1.0
—
44.10
—
0
13
10
64
1.59
0.59
1.7
1.5
—
—
—
0
0
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
6
35
1.73
0.58
2.2
2.7
105.67
104.94
mmol/l
—
6
35
46
537
0.82
0.55
1.7
1.7
1.30
1.33
mmol/l
0.08
39
441
61
688
0.84
0.50
4.1
3.8
20.13
23.90
%
1.37
30
326
10
69
1.47
0.45
1.7
1.6
—
—
—
0
0
34
286
1.22
0.45
19.1
21.6
1.95
1.34
inr
—
6
43
0
15
0.00
0.41
0.0
1.1
—
1.06
—
0
10
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
5
35
1.44
0.39
1.0
1.3
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
13
168
0.76
0.37
1.1
1.4
—
—
—
0
0
6
45
1.34
0.34
1.3
1.6
—
—
—
0
0
79
845
0.90
0.29
2.1
2.0
90.87
94.83
pmol/l
0.38
63
428
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
266.00
—
0
5
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
2.4
—
48.22
—
0
9
87
909
0.93
0.18
3.0
2.4
—
—
—
0
0
132
1355
0.94
0.16
2.9
4.3
18.37
11.93
mm/h
3.61
123
1230
36
340
1.07
0.10
1.3
1.3
10.17
1.63
u/ml
0.42
13
89
5
60
0.83
0.08
1.2
1.3
—
—
—
0
0
68
660
1.04
0.08
2.2
3.2
915.15
1232.98
ng/l
0.54
60
567
6
72
0.83
0.07
1.3
1.6
—
132.00
—
0
5
70
717
0.97
0.06
3.2
4.0
8.37
8.36
mg/mmol
0.00
47
444
13
123
1.06
0.01
1.6
3.9
1.50
2.06
mmol/l
—
6
96
160
1599
1.00
0.00
52.4
14.2
34.15
39.94
%
7.94
96
1043
18
177
1.02
0.00
1.3
1.8
1.28
1.70
%
1.53
13
148
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
9.55
—
0
8
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
20
200
1.00
0.00
1.3
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
1683.80
—
0
5
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
5
49
1.02
0.00
1.8
1.6
—
—
—
0
0
7
70
1.00
0.00
1.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
6.8
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_PANCREAS_DUCTAL_EXALLC – Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).